FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965805984> ?p ?o ?g. }

• W1965805984 endingPage "e38111" @default.
• W1965805984 startingPage "e38111" @default.
• W1965805984 abstract "Recent studies have shown that a new generation of synthetic agonist of Toll-like receptor (TLR) 9 consisting a 3'-3'-attached structure and a dCp7-deaza-dG dinucultodie shows more potent immunostimulatory effects in both mouse and human than conventional CpG oligonucleotides. Radiation therapy (RT) provides a source of tumor antigens that are released from dying, irradiated, tumor cells without causing systemic immunosuppression. We, therefore, examined effect of combining RT with a designer synthetic agonist of TLR9 on anti-tumoral immunity, primary tumor growth retardation and metastases in a murine model of lung cancer.Grouped C57BL/6 and congenic B cell deficient mice (B(-/-)) bearing footpad 3LL tumors were treated with PBS, TLR9 agonist, control oligonucelotide, RT or the combination of RT and TLR9 agonist. Immune phenotype of splenocytes and serum IFN-γ and IL-10 levels were analyzed by FACS and ELISA, 24 h after treatment. Tumor growth, lung metastases and survival rate were monitored and tumor specific antibodies in serum and deposition in tumor tissue were measured by ELISA and immunofluorescence.TLR9 agonist expanded and activated B cells and plasmacytoid dendritic cells in wild-type mice and natural killer DCs (NKDCs) in B cell-deficient (B(-/-)) mice bearing ectopic Lewis lung adenocarcinoma (3LL). Combined RT with TLR9 agonist treatment inhibited 3LL tumor growth in both wild type and B(-/-) mice. A strong tumor-specific humoral immune response (titer: 1/3200) with deposition of mouse IgG auto-antibodies in tumor tissue were found in wildtype mice, whereas the number of tumor infiltrating NKDCs increased in B(-/-) mice following RT+ TLR9 agonist therapy. Furthermore, mice receiving combination therapy had fewer lung metastases and a higher survival than single treatment cohorts.Combination therapy with TLR9 agonist and RT induces systemic anti-tumoral humoral response, augments tumoral infiltration of NKDCs, reduces pulmonary metastases and improves survival in a murine model of 3LL cancer." @default.
• W1965805984 created "2016-06-24" @default.
• W1965805984 creator A5000018805 @default.
• W1965805984 creator A5002808615 @default.
• W1965805984 creator A5008584033 @default.
• W1965805984 creator A5048894919 @default.
• W1965805984 creator A5055510159 @default.
• W1965805984 creator A5069014764 @default.
• W1965805984 creator A5088791437 @default.
• W1965805984 date "2012-05-30" @default.
• W1965805984 modified "2023-10-16" @default.
• W1965805984 title "An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy" @default.
• W1965805984 cites W1497172665 @default.
• W1965805984 cites W1503899313 @default.
• W1965805984 cites W1839872679 @default.
• W1965805984 cites W1882089686 @default.
• W1965805984 cites W1917892434 @default.
• W1965805984 cites W1964196894 @default.
• W1965805984 cites W1977080220 @default.
• W1965805984 cites W1981015419 @default.
• W1965805984 cites W1982649860 @default.
• W1965805984 cites W1995744610 @default.
• W1965805984 cites W2002915111 @default.
• W1965805984 cites W2016612145 @default.
• W1965805984 cites W2017614316 @default.
• W1965805984 cites W2023955378 @default.
• W1965805984 cites W2024309898 @default.
• W1965805984 cites W2028388022 @default.
• W1965805984 cites W2033063638 @default.
• W1965805984 cites W2039461003 @default.
• W1965805984 cites W2047495833 @default.
• W1965805984 cites W2049399563 @default.
• W1965805984 cites W2057183299 @default.
• W1965805984 cites W2062106419 @default.
• W1965805984 cites W2068975016 @default.
• W1965805984 cites W2078794780 @default.
• W1965805984 cites W2088792252 @default.
• W1965805984 cites W2090640877 @default.
• W1965805984 cites W2111819461 @default.
• W1965805984 cites W2114066561 @default.
• W1965805984 cites W2117280704 @default.
• W1965805984 cites W2117878645 @default.
• W1965805984 cites W2127733313 @default.
• W1965805984 cites W2128599664 @default.
• W1965805984 cites W2143360501 @default.
• W1965805984 cites W2146593422 @default.
• W1965805984 cites W2160613616 @default.
• W1965805984 cites W2161228679 @default.
• W1965805984 cites W2328513034 @default.
• W1965805984 doi "https://doi.org/10.1371/journal.pone.0038111" @default.
• W1965805984 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3364192" @default.
• W1965805984 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22666458" @default.
• W1965805984 hasPublicationYear "2012" @default.
• W1965805984 type Work @default.
• W1965805984 sameAs 1965805984 @default.
• W1965805984 citedByCount "55" @default.
• W1965805984 countsByYear W19658059842012 @default.
• W1965805984 countsByYear W19658059842013 @default.
• W1965805984 countsByYear W19658059842014 @default.
• W1965805984 countsByYear W19658059842015 @default.
• W1965805984 countsByYear W19658059842016 @default.
• W1965805984 countsByYear W19658059842017 @default.
• W1965805984 countsByYear W19658059842018 @default.
• W1965805984 countsByYear W19658059842019 @default.
• W1965805984 countsByYear W19658059842020 @default.
• W1965805984 countsByYear W19658059842021 @default.
• W1965805984 countsByYear W19658059842022 @default.
• W1965805984 countsByYear W19658059842023 @default.
• W1965805984 crossrefType "journal-article" @default.
• W1965805984 hasAuthorship W1965805984A5000018805 @default.
• W1965805984 hasAuthorship W1965805984A5002808615 @default.
• W1965805984 hasAuthorship W1965805984A5008584033 @default.
• W1965805984 hasAuthorship W1965805984A5048894919 @default.
• W1965805984 hasAuthorship W1965805984A5055510159 @default.
• W1965805984 hasAuthorship W1965805984A5069014764 @default.
• W1965805984 hasAuthorship W1965805984A5088791437 @default.
• W1965805984 hasBestOaLocation W19658059841 @default.
• W1965805984 hasConcept C104317684 @default.
• W1965805984 hasConcept C121608353 @default.
• W1965805984 hasConcept C126322002 @default.
• W1965805984 hasConcept C150194340 @default.
• W1965805984 hasConcept C159654299 @default.
• W1965805984 hasConcept C170493617 @default.
• W1965805984 hasConcept C189976730 @default.
• W1965805984 hasConcept C190727270 @default.
• W1965805984 hasConcept C203014093 @default.
• W1965805984 hasConcept C2777701055 @default.
• W1965805984 hasConcept C2777847059 @default.
• W1965805984 hasConcept C2778938600 @default.
• W1965805984 hasConcept C2779013556 @default.
• W1965805984 hasConcept C2779138994 @default.
• W1965805984 hasConcept C2908999202 @default.
• W1965805984 hasConcept C502942594 @default.
• W1965805984 hasConcept C55493867 @default.
• W1965805984 hasConcept C71924100 @default.
• W1965805984 hasConcept C86803240 @default.
• W1965805984 hasConcept C8891405 @default.
• W1965805984 hasConceptScore W1965805984C104317684 @default.

• next